GHK-Cu
Anti-Aging Compound
A naturally occurring copper tripeptide that promotes tissue remodeling, wound healing, and collagen synthesis in animal and in vitro studies. Premium Research Peptide.
NOT FOR HUMAN CONSUMPTION - FOR RESEARCH PURPOSES ONLY
Certificate of Analysis
Third Party Tested by accredited US laboratories
| Variant | GHK-Cu 50mg |
| Lot # | B1111 |
| Labeled | 50mg |
| Actual | 59.26mg |
| Tested | Feb 4, 2025 |
| Variant | GHK-Cu 100mg |
| Lot # | B0111 |
| Labeled | 100mg |
| Actual | 107.58mg |
| Tested | Feb 4, 2025 |
Frequently Researched Together
Popular for skin health


How GHK-Cu Works
GHK-Cu is a naturally occurring tripeptide that binds with copper to create a powerful regenerative complex. Released from damaged collagen as an injury signal, it orchestrates healing by modulating thousands of genes involved in tissue repair, inflammation control, and cellular protection.
Upregulates 59% of affected genes
Activates 47 DNA repair genes
Suppresses inflammatory pathways
Stimulates type I & III collagen
Increases elastin production
Enhances ECM remodeling
Delivers copper to cells
Activates SOD antioxidant
Supports wound healing enzymes
GHK-Cu affects more human genes than any other studied peptide — modulating 31.2% of the human genome.
| Genes Upregulated | 1,942 |
| Genes Downregulated | 762 |
| DNA Repair Genes | ↑ 47 genes |
| Antioxidant Genes | ↑ 14 genes |
What Research Has Shown
Summary of clinical and preclinical findings
Objective measurements from clinical studies
Natural GHK-Cu levels decrease significantly with age
Beyond Skin Rejuvenation
Other benefits observed in research
Research shows GHK-Cu significantly improves hair growth parameters
Multiple pathways contribute to enhanced healing
| Angiogenesis | ↑ Enhanced |
| Fibroblast migration | ↑ 70% faster |
| Collagen deposition | ↑ Increased |
| Inflammatory response | ↓ Reduced |
GHK-Cu acts as a master regulator of cellular health
Multiple mechanisms combat oxidative stress
| SOD activity | ↑ Increased |
| Catalase expression | ↑ Enhanced |
| Free radical scavenging | ↑ Improved |
| Lipid peroxidation | ↓ 38% |
Safety Profile from Research
What clinical studies report
GHK-Cu has demonstrated an excellent safety profile across multiple studies with minimal adverse effects.
Copper toxicity is theoretically possible with extreme overuse but has not been reported in clinical studies.
- · Normal therapeutic doses well below toxic threshold
- · Body has efficient copper regulation mechanisms
- · No cases reported in published literature at research doses
| Topical 2-4% | <1% |
| Injectable 1-2mg | 2% |
💡 Most discontinuations due to protocol non-compliance, not adverse effects
- No serious adverse events reported in any published clinical trial.
- Safety profile comparable to or better than standard cosmetic ingredients.
- Long history of safe use in cosmetic formulations since 1980s.
Compound Information
Technical specifications
| Type | Copper-peptide complex |
| CAS Number | 89030-95-5 |
| MW (free peptide) | 340.38 g/mol |
| MW (with copper) | 401.91 g/mol |
| Amino Acids | 3 (tripeptide) |
| Sequence | Gly-His-Lys |
| Formula | C₁₄H₂₄N₆O₄·Cu |
| Origin | Human plasma |
| Primary research | Regenerative medicine |
| Clinical studies | 50+ published |
| Commercial use | Cosmetics since 1980s |
Frequently Asked Questions
Common questions about GHK-Cu research
Sources & References
Peer-reviewed research
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.